Showing results (91-100 of 136) with videos related to

Sort By:
Pageof 14
Mabs|June 17, 2020
Characterization of concurrent target suppression by JNJ-61178104, a bispecific antibody against human tumor necrosis factor and interleukin-17ASongmao Zheng, Fang Shen, Brian Jones, et al.
Scientific Reports|November 25, 2024
Catalpol improved energy metabolism and inflammation through the SIRT5-mediated signaling pathway to ameliorate myocardial injuryZihan Zheng, YiZhen Liu, Danli Chen, et al.
Experimental Cell Research|November 25, 2019
SIRT6 inhibits cholesterol crystal-induced vascular endothelial dysfunction via Nrf2 activationZhen Jin, Yunfang Xiao, Feng Yao, et al.
Atherosclerosis|August 16, 2023
Deficiency of protein inhibitor of activated STAT3 exacerbates atherosclerosis by modulating VSMC phenotypic switchingHaole Liu, Jingyi Zhang, Ziyang Xue, et al.
Clinical Pharmacology and Therapeutics|October 1, 2020
Model-Based Cellular Kinetic Analysis of Chimeric Antigen Receptor-T Cells in HumansCan Liu, Vivaswath S Ayyar, Xirong Zheng, et al.
Proteome Science|January 4, 2022
TMT-based quantitative proteomic profiling of human monocyte-derived macrophages and foam cellsYali Zhang, Yu Fu, Linying Jia, et al.
Molecular Immunology|March 10, 2009
Impact of methionine oxidation on the binding of human IgG1 to Fc Rn and Fc gamma receptorsAndrea Bertolotti-Ciarlet, Weirong Wang, Rebecca Lownes, et al.
Histochemistry and Cell Biology|March 4, 2020
MiR-145 alleviates Hcy-induced VSMC proliferation, migration, and phenotypic switch through repression of the PI3K/Akt/mTOR pathwayMinghao Zhang, Fan Li, Xiuyu Wang, et al.
Biochemical Pharmacology|August 2, 2021
HDAC3 inhibitor suppresses endothelial-to-mesenchymal transition via modulating inflammatory response in atherosclerosisLifang Chen, Chenxu Shang, Bo Wang, et al.
Frontiers in Pharmacology|May 10, 2021
Hydroxytyrosol Acetate Inhibits Vascular Endothelial Cell Pyroptosis via the HDAC11 Signaling Pathway in AtherosclerosisFeng Yao, Zhen Jin, Xiaohan Lv, et al.
Pageof 14